Kellan Ashley, MD
Interventional Cardiology · Jackson, MSNPI 1790714954
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 483 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 39 manufacturers reported payments, led by Abiomed at 40.5% of the total.
Across 483 payments — averaging $36.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$7K
- Edwards Lifesciences$3K
- Abbott$1K
- Boston Scientific$1K
- Inari Medical, Inc.$827
- Medtronic$809
- plus $4K from 33 others
What the payments were for
- Travel & lodging$8795%
- Food & beverage$16,86395%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 175 | $7,191 |
| Edwards Lifesciences | 42 | $2,506 |
| Abbott | 34 | $1,144 |
| Boston Scientific | 19 | $1,053 |
| Inari Medical, Inc. | 34 | $827 |
| Medtronic(2 entities) | 19 | $809 |
| Pfizer | 33 | $630 |
| Novartis | 21 | $338 |
| Boehringer Ingelheim | 8 | $331 |
| Livanova USA, Inc. | 4 | $296 |
| Penumbra, Inc. | 2 | $290 |
| AstraZeneca | 7 | $195 |
| E.r. Squibb & Sons, L.L.C. | 14 | $191 |
| Amgen | 12 | $176 |
| Johnson & Johnson | 8 | $123 |
| Heartflow, Inc. | 1 | $121 |
| Shockwave Medical, Inc | 2 | $120 |
| Irhythm Technologies, Inc. | 2 | $120 |
| Lantheus Medical Imaging, Inc. | 1 | $120 |
| Chiesi USA, Inc. | 1 | $111 |
| Idorsia Pharmaceuticals US Inc | 1 | $108 |
| BTG International Inc. | 1 | $101 |
| Cardiva Medical, Inc. | 5 | $97 |
| Stryker | 5 | $92 |
| Gilead | 5 | $77 |
| Astellas Pharma US Inc | 4 | $77 |
| Braemar Manufacturing, LLC | 1 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| Actelion Pharmaceuticals US, Inc. | 2 | $64 |
| Merck | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 3 | $45 |
| United Therapeutics Corporation | 1 | $35 |
| Philips North America LLC | 2 | $33 |
| GE HealthCare | 2 | $31 |
| Imperative Care, Inc | 1 | $30 |
| Akcea Therapeutics, Inc. | 2 | $29 |
| Bridgebio Pharma, Inc. | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Bayer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$2,680
- FLOWTRIEVER CATHETER, S$505
- Indigo System$290
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$276
- CT THROMBECTOMY SYSTEM KIT$262
- CoreValve Evolut$259
- WATCHMAN Access System$254
- SAPIEN 3 Ultra RESILIA$249
- Edwards SAPIEN 3 Transcatheter Heart Valve$213
- COREVALVE EVOLUT R$162
- Perclose ProGlide suture mediated closure system$138
- EVOQUE$132
- MitraClip$122
- FFRct$121
- LifeSPARC System$120
- GENERAL - STRUCTURAL HEART$120
- Definity$120
- TRICLIP$117
- FARXIGA$116
- KENGREAL$111
How this compares
$17,756 in reported general payments places this provider in the 65th percentile of 65 interventional cardiology providers in Mississippi.
See all interventional cardiology providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 55 | $77,407 |
| EliquisApixaban | 83 | $74,867 |
| XareltoRivaroxaban | 35 | $36,388 |
| JardianceEmpagliflozin | 29 | $35,712 |
| FarxigaDapagliflozin Propanediol | 36 | $30,393 |
| Metoprolol Succinate | 106 | $1,864 |
| Isosorbide Dinitrate | 12 | $1,650 |
| ClopidogrelClopidogrel Bisulfate | 59 | $949 |
| Carvedilol | 121 | $887 |
| Rosuvastatin Calcium | 57 | $721 |
| Losartan Potassium | 68 | $692 |
| Furosemide | 90 | $614 |
| Atorvastatin Calcium | 79 | $602 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 21 | $464 |
| Spironolactone | 64 | $420 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $338 | $77,40755 claims |
| PfizerEliquis | $630 | $74,86783 claims |
| Johnson & JohnsonXarelto | $123 | $36,38835 claims |
| Boehringer IngelheimJardiance | $331 | $35,71229 claims |
| AstraZenecaFarxiga | $195 | $30,39336 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 65 interventional cardiology providers in Mississippi.
Other interventional cardiology in Jackson
- John WinscottJackson$482K
- William CrowderJackson$331K
- James BennettJackson$160K
- Brett BennettJackson$126K
- Alejandro Lemor FerrandJackson$37K
- David YoungJackson$28K
- Richard GuynesJackson$26K
- William NicholsJackson$25K
- Catherine LoweJackson$21K
- Jeremy WhiteJackson$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.